drugset / Trial / NCT05960201
Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma
NaSingle-groupOpen-labelDiagnostic
Summary
This study aims to explore the diagnostic validity of \[18F\]FES PET/CT for the evaluation of axillary lymph node metastasis in patients with invasive lobular breast cancer having clinically suspected or confirmed axillary lymph node metastasis.
Timeline
- Start
- 2023-08-10
- Primary completion
- 2024-08-20
- Completion
- 2024-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | F-18 16 Alpha-Fluoroestradiol | Diagnostic / imaging agent | 111 mbq | Other |
| Subject | F-18 16 Alpha-Fluoroestradiol | Diagnostic / imaging agent | 222 mbq | Other |